Anne Stevens

Anne Stevens is a declared insider of Aequus Pharmaceuticals Inc., with filings sourced from SEDI. Over a trading history stretching from 6 May 2016 to 15 March 2019, the count stands at 4 filings.

In open-market terms, that means 1 purchase worth €281 on one side and 3 sales worth €4,017 on the other. Netting one side against the other leaves €3,737 of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2019 alone, the filings show no purchases and 1 sale.

On 23 May 2019 came the latest disclosure, an open-market sale for €1,941 in Aequus Pharmaceuticals Inc. The last purchase on record was published on 16 November 2016, which is 3,631 days ago. Filings reach the SEDI feed a median of 17 days after the trade. This delay matters because a trade only becomes useful information once it is public. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEDI. Past trades are no guide to future returns.